Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 2,289.5 | 2,122.4 | 1,814.3 | 1,794.9 | 1,597.9 |
Revenue growth | 7.9% | 17.0% | 1.1% | 12.3% | |
Cost of goods sold | 452.8 | 230.8 | -1,019.3 | 430.4 | 453.4 |
Gross profit | 1,836.6 | 1,891.5 | 2,833.6 | 1,364.4 | 1,144.5 |
Gross margin | 80.2% | 89.1% | 156.2% | 76.0% | 71.6% |
Research and development | 200.1 | 26.3 | 83.0 | 392.6 | 117.9 |
General and administrative | 182.8 | 181.7 | 103.4 | 61.9 | 106.4 |
EBITA | 1,434.2 | 1,662.9 | 2,614.6 | 1,390.7 | 1,084.0 |
EBITA margin | 62.6% | 78.4% | 144.1% | 77.5% | 67.8% |
Amortization of intangibles | 23.0 | 23.1 | 23.9 | 33.3 | 33.3 |
EBIT | 1,411.2 | 1,639.9 | 2,590.7 | 1,357.4 | 1,050.7 |
EBIT margin | 61.6% | 77.3% | 142.8% | 75.6% | 65.8% |
Pre-tax income | 1,241.2 | 1,702.0 | 2,461.4 | 1,517.9 | 1,343.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | 619.7 | 975.0 | 2,348.5 | 1,377.7 | 1,210.0 |
Net margin | 27.1% | 45.9% | 129.4% | 76.8% | 75.7% |
|
Diluted EPS | $1.49 | $2.60 | | | |
Shares outstanding (diluted) | 414.8 | 375.5 | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|